Latest News of PDSB
PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
By Yahoo! Finance |
1 week ago
The company is considering Phase III trials for IMMUNOCERV and consulting with experts. They differentiate their approach from Merus by focusing on HPV16-specific head and neck cancer....